Skip to main content

Preventative Measures for Carriers

Reducing the Risk of Colon Cancer

Here are some of the preventive steps you and your doctor can take if your genetic test indicates a risk of developing an inherited cancer:
  • Increased Surveillance Colonoscopy every one to two years beginning at age 20-25 or 5-10 years before the earliest age of a diagnosed colorectal cancer in your family, whichever comes first. Colonoscopy annually after age 40.
  • Preventive Surgery
  • If colon cancer (or an advanced precancerous polyp) is diagnosed in a patient with HNPCC, a full, rather than partial, colectomy is recommended.
  • In carefully selected people, for example, those not willing or able to undergo periodic screening, preventive colectomy may be an option based on a positive genetic test result for HNPCC.
  • Preventive Drug Therapies for Colorectal Cancer: Different drugs for the prevention of colorectal cancer are currently being researched for individuals with HNPCC. None of these drugs are currently approved by the FDA for this purpose.
  • Increased Surveillance for Endometrial Cancer Gynecologic exam, transvaginal ultrasound, endometrial aspirate, and CA-125 every 1-2 years, starting at age 25-35.
  • Preventive Surgery for Endometrial and Ovarian Cancer: Removal of the uterus and ovaries may be an option if colorectal cancer is detected and may also be considered when childbearing is concluded.
  • Increased Surveillance for Other HNPCC-Related CancersThese screening guidelines are necessary in some situations:
  • For stomach cancer, gastroscopy every 1-2 years starting at age 30-35.
  • For urinary tract cancer, ultrasonography or urine cytology every 1-2 years starting at age 30-35.
» Understanding Inherited Colorectal Cancer: Adenomatous Polyposis Syndromes
A genetic test for hereditary nonpolyposis colorectal cancer (HNPCC)
Labels:

Comments

Post a Comment

Popular posts from this blog

Get the Facts About Genetic Colon Cancer

Get the Facts: http://genefacts.org Lynch syndrome is a cancer predisposition syndrome caused by inherited mutations in genes responsible for correcting DNA replication errors. Individuals with Lynch syndrome have a greatly increased risk for colorectal, endometrial, and stomach cancers, and a moderately increased risk for other cancers. Key Points 1-3% of colon cancers attributable to Lynch syndrome Dominant inheritance with reduced penetrance (not all patients with mutations will manifest disease) Diagnosis based on clinical and family history, tumor pathology and/or genetic testing Screening and prophylactic surgeries effective in reducing some, but not all cancer risks Mutations in any of several genes can cause the syndrome
Post a Comment
Read more

Cancer Survivors

Just read a story about one woman's cancer experience. I bet everyone has a story about what goes through your mind when you are told you have cancer. Her thought were about her stunned family members, one crying and the other in shock. I bet there are quite a few stories that could be qualitatively studied. Those experiences could help nurses better help patients during this time.
1 comment
Read more

My Publication, "Hereditary non-polyposis colon cancer: change the name to protect the innocent." Cited in World Journal of Gastroenterology

Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration t... Hsi-Hsien Hsu, Wei-Wen Kuo, Da-Tong Ju... World journal of gastroenterology : WJG 11/2014 20(44):16665-73. World Journal of Gastroenterology : WJG 11/2014; 20(44):16665-73. DOI: 10.3748/wjg.v20.i44.16665 Source: PubMed ABSTRACT To investigate the effects of 17β-estradiol via estrogen receptors (ER) or direct administration of ER agonists on human colorectal cancer. LoVo cells were established from the Bioresource Collection and Research Center and cultured in phenol red-free DMEM (Sigma, United States). To investigate the effects of E2 and/or ER selective agonists on cellular proliferation, LoVo colorectal cells were treated with E2 or ER-selective agonists for 24 h and 48 h and subjected to the MTT (Sigma) assay to find the concentration. And investigate the effects of E2 and/or ER selective agonists on cell used western immunoblotting to find out the diver...
Post a Comment
Read more